VK-1727
VK-1727 is a selective EBNA1 inhibitor that suppresses EBV-positive cell proliferation and metabolism by blocking EBNA1-DNA binding, showing specificity by sparing EBV-negative cells. It is a key research tool for investigating EBNA1's role in diseases like multiple sclerosis, with utility in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
VK1727
Field of Research
Infectious Disease & Virology, Molecular Biology
Purity
98.07% (May vary between batches)
Solubility
DMSO:80 mg/mL (177.18 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.31 mM)
Smiles
COC (C1=CC=CC (C#CC (C=C2) =CC=C2OC3CCOCC3) =C1C4=CC=C (C=CN5) C5=C4) =O
Molecular Formula
C29H25NO4
Molecular Weight
451.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC214304L3V 200 µL
LCLAT1 (NM_001002257) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
